India Issues Standard Treatment Guidelines for Dermatological Disorders Across AYUSH Systems

Skin disorders range from relatively mild conditions, such as certain forms of dermatitis, to chronic inflammatory diseases, infections, autoimmune conditions, and skin cancers. Correct diagnosis is important because different conditions can produce similar symptoms while requiring very different treatments. India's Ministry of AYUSH has issued standard treatment guidelines for dermatological disorders covering Ayurveda, Siddha, Unani, and Homoeopathy, with the inclusion of Yoga. According to the announcement, the document was prepared through the AYUSH Vertical of the Directorate General of Health Services and the Ministry of Health and Family Welfare. The stated objective is to promote uniformity, quality assurance, and evidence-informed clinical practice across the participating systems. Standardized guidelines can help establish consistent approaches to assessment, documentation, treatment selection, and patient management. They may also support professional training and provide a framework for evaluating whether clinical care follows recommended procedures. In dermatology, accurate diagnosis is particularly important when patients experience persistent itching, skin discoloration, ulcers, spreading rashes, recurrent infections, or unexplained changes in moles and other skin lesions. Some skin conditions require laboratory testing, skin biopsies, prescription medication, or urgent specialist assessment. Delayed treatment of serious infections, autoimmune disease, or skin cancer can lead to complications. Traditional systems of medicine also vary in their theoretical foundations, diagnostic approaches, and available clinical evidence. The existence of a standardized guideline should not be interpreted as proof that every treatment included in a traditional medical system is effective or safe for every condition. Herbal products may cause allergic reactions, interact with prescribed medicines, or vary in composition. Certain products may also contain contaminants or undeclared ingredients. Patients should disclose all medicines and supplements they use to their healthcare professionals. Medical significance: The announcement is relevant to the regulation and standardization of traditional healthcare practice in India. The clinical value of individual treatments should still be assessed according to the quality of supporting evidence, safety data, and the patient's medical needs.